89bio slides on stock offering to fund MASH drug

Akero Therapeutics

27/01/2025 21:56

**  Shares of 89Bio  ETNB.O  down 6.2% post-market to $8.44
as co looks to raise equity
  
    ** ETNB shares 
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  

(Lance Tupper is a Reuters market analyst. The views expressed
are his own)
((lance.tupper@tr.com 1-646-279-6380))